Lung Cancers Completed Phase 2 Trials for Iloprost (DB01088)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00084409Iloprost in Preventing Lung Cancer in Patients at High Risk for This DiseasePrevention